Entitäten Zur letzten Folie zurück PACET-CUP Open labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated CUP.
{}